Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCIO-469 in Rheumatoid Arthritis
NCT00043732Phase 2Completed
- Sponsor
- Scios Inc.
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of talmapimod in rheumatoid arthritis (RA), sponsored by Scios Inc.. Status: completed.
02
Drugs
talmapimod
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00043732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043732.